If you're already a member, please log in. If not, please register.


Follow Us

Biotech Approvals

Reasonable Regulations

Biotech approvals are key to ensuring farmers have access to technologies – from new seed varieties to crop protectants – that help them successfully grow a high quality crop. Illinois Soybean Growers (ISG) does not support unnecessary barriers put between soybean farmers and the tools needed for sustainable soybean production.



June 2018 Update


Everyone involved with production agriculture in Illinois has a critical role to play in the proper stewardship of new products, such as dicamba-based herbicides, including strict adherence to all label guidelines. ISA continues to work with industry partners to inform growers about specific requirements related to dicamba use in Illinois.


November 2016 Update


The EPA approved some of Monsanto’s new dicamba-based weed killers. Specifically, the EPA gave the green light on Monsanto’s XtendiMax herbicide for use on Roundup Ready 2 Xtend biotech soybeans as well as its Bollgard II XtendFlex cotton.


It has not yet decided on the company’s Roundup Xtend herbicide, which is a blend of glyphosate and dicamba.




October 2016 Update


A meeting scheduled for October 18 for a scientific panel to review the cancer-causing potential of glyphosate was postponed by the Environmental Protection Agency (EPA). With the delay, it is unlikely the agency will complete the full review under the Obama Administration.


September 2016 Update


The EPA concluded that glyphosate is unlikely to cause cancer. The agency said it will bring together independent scientists in October to review its evaluation of whether the pesticide does cause cancer in humans.


Glyphosate’s safety was called into question after the World Health Organization’s International Agency for Research on Cancer (IARC) suggested that the chemical is likely carcinogenic.